GGrantIndex
Sort

40,608 grants matching prostate cancer

Diet Assessment System for Cancer Control Applications

$522,163
Rick Weiss · Viocare, Inc. · R44 · FY2008 · CA

Determining the Functional Contribution of Prostate Tumor Microenvironment in Bon

$522,160
Raghu Kalluri · University Of Tx Md Anderson Can Ctr · U54 · FY2012 · CA

Laboratory of Genitourinary Cancer Pathogenesis Microscopy Core Facility

$521,931
Ross Lake · Division Of Basic Sciences - Nci · ZIC · FY2023 · CA

Project 3: Targeting SK2/S1P Signaling for the Regulation of c-Myc and Tumor Suppression

$521,898
Carolyn D Britten · Medical University Of South Carolina · P01 · FY2018 · CA

Novel therapeutics dual targeting intracrine androgen synthesis and AR for advanced prostate cancer

$521,811
Allen C Gao · University Of California At Davis · R01 · FY2025 · CA

Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth

$521,804
Theresa A Guise · Indiana University Indianapolis · U01 · FY2014 · CA

Inhibiting Rev1-mediated translesion DNA synthesis for cancer therapy

$521,760
Jiyong Hong · Duke University · R01 · FY2025 · CA

Inhibiting Rev1-mediated translesion DNA synthesis for cancer therapy

$521,760
Jiyong Hong · Duke University · R01 · FY2024 · CA

Exploiting ferroportin for cancer imaging and therapy

$521,740
Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2021 · CA

Exploiting ferroportin for cancer imaging and therapy

$521,740
Jan Grimm · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

Drug Discovery for Fatty Acid Synthase in Oncology

$521,711
Jeffrey W Smith · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · CA

Prostate Cancer Harbinger Genes

$521,660
Brigham And Women'S Hospital · R01 · FY2005 · AG

Prostate Cancer Harbinger Genes

$521,660
Brigham And Women'S Hospital · R01 · FY2002 · AG

Prostate Cancer Harbinger Genes

$521,660
Brigham And Women'S Hospital · R01 · FY2003 · AG

Robot-Enabled Natural Orifice Prostatectomy

$521,629
Robert James Webster · Vanderbilt University · R01 · FY2021 · EB

Mcl-1 in apoptosis and signal transduction: a structure/function approach

$521,604
Maurizio Pellecchia · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · CA

GEISINGER CLINICAL ONCOLOGY PROGRAM

$521,602
Geisinger Medical Center · U10 · FY2002 · CA

IDENTIFICATION OF ENVIRONMENTAL AGENTS ALTERING PROSTATE CANCER BEHAVIOR

$521,476
Duke University · · FY2008 · Department of Defense

DRUG DELIVERY CPPs

$521,444
Rudolph Juliano · Univ Of North Carolina Chapel Hill · P01 · FY2009 · GM

Bay Area Tumor Institute CCOP

$521,201
James Feusner · Bay Area Tumor Institute · U10 · FY2009 · CA

Vaccine and radiation for the therapy of human cancers

$521,180
James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Vaccine and Drug Combination Therapy for Human Cancers

$521,180
James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

Unravel a novel metabolic pathway orchestrating prostate cancer progression and therapeutic resistance

$521,160
Hui-Kuan Lin · Duke University · R01 · FY2025 · CA

Genomics Core

$521,135
David B. Solit · Sloan-Kettering Inst Can Research · P01 · FY2021 · CA

Clinical validation of the HD-CTC fluid biopsy in early detection of lung cancer.

$521,105
Peter Kuhn · Scripps Research Institute, The · R33 · FY2014 · CA